|
GB9702088D0
(en)
|
1997-01-31 |
1997-03-19 |
Pharmacia & Upjohn Spa |
Matrix metalloproteinase inhibitors
|
|
ES2202796T3
(es)
*
|
1997-02-03 |
2004-04-01 |
Pfizer Products Inc. |
Derivados de acidos arilsulfonilaminohidroxamicos.
|
|
KR100352316B1
(ko)
|
1997-07-31 |
2002-09-12 |
더 프록터 앤드 갬블 캄파니 |
메탈로프로테아제억제제로서사용되는술포닐아미노치환히드록삼산유도체
|
|
WO2000037433A1
(en)
*
|
1998-12-18 |
2000-06-29 |
Abbott Laboratories |
Inhibitors of matrix metalloproteinases
|
|
US6225311B1
(en)
|
1999-01-27 |
2001-05-01 |
American Cyanamid Company |
Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
|
|
US6277885B1
(en)
|
1999-01-27 |
2001-08-21 |
American Cyanamid Company |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6753337B2
(en)
|
1999-01-27 |
2004-06-22 |
Wyeth Holdings Corporation |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
|
|
CN1178915C
(zh)
|
1999-01-27 |
2004-12-08 |
惠氏控股有限公司 |
含有炔基的异羟肟酸衍生物、其制备及其作为基质金属蛋白酶抑制剂/TNF-α转变酶抑制剂的用途
|
|
US6340691B1
(en)
|
1999-01-27 |
2002-01-22 |
American Cyanamid Company |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
|
|
US6946473B2
(en)
*
|
1999-01-27 |
2005-09-20 |
Wyeth Holdings Corporation |
Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
|
|
US6200996B1
(en)
|
1999-01-27 |
2001-03-13 |
American Cyanamid Company |
Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
|
|
US6313123B1
(en)
|
1999-01-27 |
2001-11-06 |
American Cyanamid Company |
Acetylenic sulfonamide thiol tace inhibitors
|
|
US6762178B2
(en)
|
1999-01-27 |
2004-07-13 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6326516B1
(en)
|
1999-01-27 |
2001-12-04 |
American Cyanamid Company |
Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
PL350340A1
(en)
|
1999-03-03 |
2002-12-02 |
Procter & Gamble |
Alkenyl- and alkynyl-containing metalloprotease inhibitors
|
|
HK1044935A1
(zh)
|
1999-03-03 |
2002-11-08 |
The Procter & Gamble Company |
双异取代的金属蛋白酶抑制剂
|
|
SE0100902D0
(sv)
*
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
Compounds
|
|
SE0100903D0
(sv)
*
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
Compounds
|
|
MXPA04004010A
(es)
*
|
2001-11-01 |
2004-07-23 |
Wyeth Corp |
Acidos hidroxamicos de aril sulfonamida alenicos como inhibidores de tace y metaloproteinasa de matriz.
|
|
SE0103710D0
(sv)
*
|
2001-11-07 |
2001-11-07 |
Astrazeneca Ab |
Compounds
|
|
SI1511472T1
(sl)
|
2002-05-29 |
2009-08-31 |
Merck & Co Inc |
Spojine uporabne pri zdravljenju antraksa in inhibiranju letalnega faktorja
|
|
SE0202539D0
(sv)
|
2002-08-27 |
2002-08-27 |
Astrazeneca Ab |
Compounds
|
|
GB0221246D0
(en)
*
|
2002-09-13 |
2002-10-23 |
Astrazeneca Ab |
Compounds
|
|
US7199155B2
(en)
*
|
2002-12-23 |
2007-04-03 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors
|
|
ATE457716T1
(de)
|
2002-12-30 |
2010-03-15 |
Angiotech Int Ag |
Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
|
|
BRPI0407587A
(pt)
*
|
2003-02-18 |
2006-02-14 |
Pfizer |
inibidores do vìrus da hepatite c, composições e tratamentos que os utilizam
|
|
WO2004076386A2
(en)
|
2003-02-25 |
2004-09-10 |
Topotarget Uk Limited |
Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
|
|
WO2005118529A2
(en)
*
|
2004-05-11 |
2005-12-15 |
Merck & Co., Inc. |
Process for making n-sulfonated-amino acid derivatives
|
|
US7648992B2
(en)
|
2004-07-05 |
2010-01-19 |
Astrazeneca Ab |
Hydantoin derivatives for the treatment of obstructive airway diseases
|
|
SE0401762D0
(sv)
*
|
2004-07-05 |
2004-07-05 |
Astrazeneca Ab |
Novel compounds
|
|
ITFI20040174A1
(it)
*
|
2004-08-03 |
2004-11-03 |
Protera S R L |
Derivati arilsolfonammidici dell'acido idrossammico ad azione inibitoria di metalloproteinasi
|
|
US20100003276A1
(en)
*
|
2004-12-07 |
2010-01-07 |
Hermes Jeffery D |
Methods for treating anthrax and inhibiting lethal factor
|
|
SE0403086D0
(sv)
*
|
2004-12-17 |
2004-12-17 |
Astrazeneca Ab |
Compounds
|
|
SE0403085D0
(sv)
*
|
2004-12-17 |
2004-12-17 |
Astrazeneca Ab |
Novel componds
|
|
TW200831488A
(en)
*
|
2006-11-29 |
2008-08-01 |
Astrazeneca Ab |
Novel compounds
|
|
EP3717481B1
(en)
|
2017-11-27 |
2023-03-01 |
Council of Scientific & Industrial Research |
Indole (sulfomyl) n-hydroxy benzamide derivatives as selective hdac inhibitors
|